The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - A DRG-based simulation model

European Journal of Medical Research

Volumn 16, Issue 12, 2011, Pages 543-548

  Wilke, Michael H ^a   Grube, R F ^a   Bodmann, K F ^b  

^a Dr Wilke GmbH Inspiringhealth   (Germany)

^b Klinikum Barnim Werner Forssmann Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ALGORITHM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE; LENGTH OF STAY; PNEUMONIA; SEPSIS; SIMULATION; VENTILATOR ASSOCIATED PNEUMONIA; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; HOSPITAL COST; OUTCOME ASSESSMENT; PATIENT MONITORING; PROTEIN DETERMINATION;

EID: 84255166999     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-16-12-543     Document Type: Article

References (24)

1. Gastmeier P, Sohr D, Geffers C, Zuschneid I, Behnke M, Ruden H. [Mortality in German intensive care units: dying from or with a nosocomial infection?]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 2005;40:267-72.
2. Brunkhorst FM. [Epidemiology, economy and practice - results of the German study on prevalence by the competence network sepsis (SepNet)]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 2006;41:43-4. (Pubitemid 43189493)
3. Moerer O, Burchardi H. [The cost of sepsis]. Der Anaesthesist 2006;55 Suppl 1:36-42.
4. Brunkhorst FM, Engel C, Ragaller M, et al. Practice and perception - a nationwide survey of therapy habits in sepsis. Critical care medicine 2008;36:2719-25.
5. Charles PE, Tinel C, Barbar S, et al. Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Critical care (London, England) 2009;13:R38.
6. Harbarth S, Albrich WC, Muller B. When once is not enough - further evidence of procalcitonin-guided antibiotic stewardship. Critical care (London, England) 2009;13:165.
7. Hochreiter M, Schroeder S. [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients]. Der Anaesthesist 2011;60:661-73.
8. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC medicine 2011;9:107.
9. Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. American journal of respiratory and critical care medicine 2008;177:498-505. (Pubitemid 351442188)
10. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Archives of internal medicine 2011;171:1322-31.
11. Tang H, Huang T, Jing J, Shen H, Cui W. Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 2009;37:497-507.
12. Saeed K, Dryden M, Bourne S, Paget C, Proud A. Reduction in antibiotic use through procalcitonin testing in patients in the medical admission unit or intensive care unit with suspicion of infection. The Journal of hospital infection 2011;78:289-92.
13. Heyland DK, Johnson AP, Reynolds SC, Muscedere J. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Critical care medicine 2011;39:1792-9.
14. Wilke M, Grube RF, Bodmann KF. Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy. European journal of medical research 2011;16:315-23.
15. Wilke MH. Multiresistant bacteria and current therapy - the economical side of the story. European journal of medical research 2010;15:571-6.
16. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group. The British journal of surgery 2000;87:1448-54.
17. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010;375:463-74.
18. Hochreiter M, Kohler T, Schweiger AM, et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Critical care (London, England) 2009;13:R83.
19. Stolz D, Smyrnios N, Eggimann P, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2009;34:1364-75.
20. Schroeder S, Hochreiter M, Koehler T, et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie 2009;394:221-6.
21. Svoboda P, Kantorova I, Scheer P, Radvanova J, Radvan M. Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery? Hepato-gastroenterology 2007;54:359-63. (Pubitemid 46724682)
22. Barbieri S, Feltracco P, Michieletto E, Basso I, Spagna A, Giron G. Demand and availability of Intensive Care beds. A study based on the data collected at the SUEM 118 Central of Padua from October 1996 to December 2001. Minerva anestesiologica 2003;69:625-34, 34-9.
23. Lin F, Chaboyer W, Wallis M. A literature review of organisational, individual and teamwork factors contributing to the ICU discharge process. Australian critical care : official journal of the Confederation of Australian Critical Care Nurses 2009;22:29-43.
24. Sidlow R, Aggarwal V. "The MICU is full": one hospital's experience with an overflow triage policy. Joint Commission journal on quality and patient safety / Joint Commission Resources 2011;37:456-60.